This brand name is authorized in Austria, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Poland, United Kingdom, United States
The drug BLENREP contains one active pharmaceutical ingredient (API):
|
1
Belantamab mafodotin
UNII DB1041CXDG - BELANTAMAB MAFODOTIN
|
|
Belantamab mafodotin is a humanised IgG1κ monoclonal antibody conjugated with a cytotoxic agent, maleimidocaproyl monomethyl auristatin F (mcMMAF). Belantamab mafodotin binds to cell surface BCMA and is rapidly internalised. Apoptosis induced by belantamab mafodotin is accompanied by markers of immunogenic cell death, which may contribute to an adaptive immune response to tumour cells. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| BLENREP Powder for concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| BLENREP Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01FX15 | Belantamab mafodotin | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1826265 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 175482 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 69857522 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 396098 |
| Country: HK | Department of Health Drug Office | Identifier(s): 67213 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9007 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1091049 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100438093 |
| Country: US | FDA, National Drug Code | Identifier(s): 0173-0896 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
